ILLUMINA INC (ILMN) Stock Fundamental Analysis

NASDAQ:ILMN • US4523271090

116.81 USD
+2.37 (+2.07%)
At close: Feb 13, 2026
116.81 USD
0 (0%)
After Hours: 2/13/2026, 8:17:17 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Overall ILMN gets a fundamental rating of 6 out of 10. We evaluated ILMN against 58 industry peers in the Life Sciences Tools & Services industry. ILMN scores excellent on profitability, but there are some minor concerns on its financial health. ILMN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • ILMN had positive earnings in the past year.
  • ILMN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ILMN reported negative net income in multiple years.
  • Of the past 5 years ILMN 4 years had a positive operating cash flow.
ILMN Yearly Net Income VS EBIT VS OCF VS FCFILMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

1.2 Ratios

  • The Return On Assets of ILMN (11.38%) is better than 91.38% of its industry peers.
  • ILMN has a Return On Equity of 29.53%. This is amongst the best in the industry. ILMN outperforms 96.55% of its industry peers.
  • ILMN has a better Return On Invested Capital (16.25%) than 91.38% of its industry peers.
Industry RankSector Rank
ROA 11.38%
ROE 29.53%
ROIC 16.25%
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ILMN Yearly ROA, ROE, ROICILMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60

1.3 Margins

  • The Profit Margin of ILMN (16.39%) is better than 89.66% of its industry peers.
  • ILMN's Profit Margin has been stable in the last couple of years.
  • ILMN has a better Operating Margin (20.41%) than 86.21% of its industry peers.
  • In the last couple of years the Operating Margin of ILMN has grown nicely.
  • ILMN has a better Gross Margin (66.74%) than 89.66% of its industry peers.
  • In the last couple of years the Gross Margin of ILMN has remained more or less at the same level.
Industry RankSector Rank
OM 20.41%
PM (TTM) 16.39%
GM 66.74%
OM growth 3Y38.39%
OM growth 5Y2.71%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
ILMN Yearly Profit, Operating, Gross MarginsILMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ILMN is still creating some value.
  • ILMN has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ILMN has more shares outstanding
  • Compared to 1 year ago, ILMN has an improved debt to assets ratio.
ILMN Yearly Shares OutstandingILMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ILMN Yearly Total Debt VS Total AssetsILMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • ILMN has an Altman-Z score of 3.92. This indicates that ILMN is financially healthy and has little risk of bankruptcy at the moment.
  • ILMN has a better Altman-Z score (3.92) than 77.59% of its industry peers.
  • ILMN has a debt to FCF ratio of 1.99. This is a very positive value and a sign of high solvency as it would only need 1.99 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.99, ILMN belongs to the top of the industry, outperforming 87.93% of the companies in the same industry.
  • ILMN has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
  • ILMN's Debt to Equity ratio of 0.42 is on the low side compared to the rest of the industry. ILMN is outperformed by 60.34% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for ILMN, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.99
Altman-Z 3.92
ROIC/WACC1.53
WACC10.61%
ILMN Yearly LT Debt VS Equity VS FCFILMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.43 indicates that ILMN should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.43, ILMN is not doing good in the industry: 77.59% of the companies in the same industry are doing better.
  • ILMN has a Quick Ratio of 1.12. This is a normal value and indicates that ILMN is financially healthy and should not expect problems in meeting its short term obligations.
  • ILMN has a worse Quick ratio (1.12) than 72.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.12
ILMN Yearly Current Assets VS Current LiabilitesILMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 97.96% over the past year.
  • ILMN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.51% yearly.
  • ILMN shows a decrease in Revenue. In the last year, the revenue decreased by -0.66%.
  • Measured over the past years, ILMN shows a small growth in Revenue. The Revenue has been growing by 6.04% on average per year.
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%

3.2 Future

  • Based on estimates for the next years, ILMN will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.14% on average per year.
  • The Revenue is expected to grow by 6.07% on average over the next years.
EPS Next Y6.75%
EPS Next 2Y10.5%
EPS Next 3Y9.64%
EPS Next 5Y12.14%
Revenue Next Year2.81%
Revenue Next 2Y4.54%
Revenue Next 3Y4.65%
Revenue Next 5Y6.07%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ILMN Yearly Revenue VS EstimatesILMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
ILMN Yearly EPS VS EstimatesILMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 24.08 indicates a rather expensive valuation of ILMN.
  • ILMN's Price/Earnings ratio is a bit cheaper when compared to the industry. ILMN is cheaper than 74.14% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.97, ILMN is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 22.56, the valuation of ILMN can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ILMN indicates a somewhat cheap valuation: ILMN is cheaper than 75.86% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.96. ILMN is around the same levels.
Industry RankSector Rank
PE 24.08
Fwd PE 22.56
ILMN Price Earnings VS Forward Price EarningsILMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ILMN indicates a rather cheap valuation: ILMN is cheaper than 81.03% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, ILMN is valued cheaply inside the industry as 86.21% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.85
EV/EBITDA 15.63
ILMN Per share dataILMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ILMN does not grow enough to justify the current Price/Earnings ratio.
  • ILMN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.57
PEG (5Y)15.96
EPS Next 2Y10.5%
EPS Next 3Y9.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ILMN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ILLUMINA INC

NASDAQ:ILMN (2/13/2026, 8:17:17 PM)

After market: 116.81 0 (0%)

116.81

+2.37 (+2.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners104.7%
Inst Owner Change-2.08%
Ins Owners0.17%
Ins Owner Change-0.21%
Market Cap17.85B
Revenue(TTM)4.34B
Net Income(TTM)703.00M
Analysts72.31
Price Target135.91 (16.35%)
Short Float %4.23%
Short Ratio3.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)7.63%
PT rev (3m)19.07%
EPS NQ rev (1m)0.77%
EPS NQ rev (3m)0.25%
EPS NY rev (1m)0.24%
EPS NY rev (3m)1.57%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)-0.18%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.23%
Valuation
Industry RankSector Rank
PE 24.08
Fwd PE 22.56
P/S 4.16
P/FCF 17.85
P/OCF 15.91
P/B 7.5
P/tB 17.11
EV/EBITDA 15.63
EPS(TTM)4.85
EY4.15%
EPS(NY)5.18
Fwd EY4.43%
FCF(TTM)6.54
FCFY5.6%
OCF(TTM)7.34
OCFY6.29%
SpS28.06
BVpS15.58
TBVpS6.83
PEG (NY)3.57
PEG (5Y)15.96
Graham Number41.24
Profitability
Industry RankSector Rank
ROA 11.38%
ROE 29.53%
ROCE 20.76%
ROIC 16.25%
ROICexc 23.32%
ROICexgc 42.83%
OM 20.41%
PM (TTM) 16.39%
GM 66.74%
FCFM 23.32%
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y3.11%
ROICexgc growth 5Y5.93%
ROICexc growth 3Y76.04%
ROICexc growth 5Y5.12%
OM growth 3Y38.39%
OM growth 5Y2.71%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.99
Debt/EBITDA 0.86
Cap/Depr 44.36%
Cap/Sales 2.85%
Interest Coverage 250
Cash Conversion 97.57%
Profit Quality 142.25%
Current Ratio 1.43
Quick Ratio 1.12
Altman-Z 3.92
F-Score7
WACC10.61%
ROIC/WACC1.53
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
EPS Next Y6.75%
EPS Next 2Y10.5%
EPS Next 3Y9.64%
EPS Next 5Y12.14%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%
Revenue Next Year2.81%
Revenue Next 2Y4.54%
Revenue Next 3Y4.65%
Revenue Next 5Y6.07%
EBIT growth 1Y154.36%
EBIT growth 3Y35.92%
EBIT growth 5Y8.92%
EBIT Next Year30.31%
EBIT Next 3Y19.36%
EBIT Next 5Y16.64%
FCF growth 1Y82.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y60.98%
OCF growth 3YN/A
OCF growth 5YN/A

ILLUMINA INC / ILMN FAQ

Can you provide the ChartMill fundamental rating for ILLUMINA INC?

ChartMill assigns a fundamental rating of 6 / 10 to ILMN.


Can you provide the valuation status for ILLUMINA INC?

ChartMill assigns a valuation rating of 5 / 10 to ILLUMINA INC (ILMN). This can be considered as Fairly Valued.


How profitable is ILLUMINA INC (ILMN) stock?

ILLUMINA INC (ILMN) has a profitability rating of 7 / 10.


What is the financial health of ILLUMINA INC (ILMN) stock?

The financial health rating of ILLUMINA INC (ILMN) is 6 / 10.


What is the expected EPS growth for ILLUMINA INC (ILMN) stock?

The Earnings per Share (EPS) of ILLUMINA INC (ILMN) is expected to grow by 6.75% in the next year.